Stock To Observe: Cantel Medical Corp. (NYSE :CMD)

Cantel Medical Corp. (NYSE :CMD) closed with gain/decline of +0.07% to $95.10 . Recent traded volume was 175,160 million shares versus to it an average volume of 314,887 million shares. The company holds 41.71M million shares outstanding and market cap of 3.967B billion. The stock’s day range was recorded between a low of $94.21 and a high $95.49. The one year high of the company is $130.92 and the one year low is $72.82.

After the last closing session, the bid price was seen at 0.01 x 1000 . The bid price represents the higher price that a buyer or buyers are willing to pay for a security. The ask price was registered at 98.00 x 900 . The ask price indicates the lower price that a seller or sellers are willing to receive for the security.

Cantel Medical Corp. (NYSE: CMD) reported financial results for its third quarter ended April 30, 2018.

Financial Highlights:

Endoscopy sales grew 18.0%, with organic growth of 8.1%, showing continued performance across our core product lines. Recurring revenue for this section was up 16.1%, and favorable product mix drove margin rate expansion. Sales in Water Purification and Filtration increased 9.2%, led by strong demand for consumables, chemistry and service. Healthcare Disposables stated year over year growth of 6.5%, with 5.3% organic, driven by the planned branded portfolio which grew by 9.0%.

The Company’s balance sheet continues to generate important cash flow and EBITDAS. The third quarter ended with cash of $51.9M and gross debt of

Net sales of $217.3M, up 13.1%, with organic sales growth of 7.6%

GAAP diluted EPS of $0.45, up 7.0%

Non-GAAP diluted EPS of $0.60, up 16.6%

GAAP net income of $18.7M, up 7.0%

Non-GAAP net income of $24.9M, up 16.6%

Cantel Medical Corp., NYSE :CMD

The average true range of Cantel Medical Corp.’s (CMD) is recorded at 2.11 and the relative strength index of the stock stands 50.26. The stock price is going above to its 52 week low with 30.60% and lagging behind from its 52 week high with -27.36%. Analyst recommendation for this stock stands at 2.30. A look on the firm performance, its monthly performance is -1.04% and a quarterly performance of -19.93%. The stock price is trading downbeat from its 200 days moving average with -11.03% and down from 50 days moving average with -4.12%.


Angela Maria

Angela writes about Dividend news of Healthcare, Services, technology, financial, energy sector companies and other global companies that traded in US market. Before pursuing a financial and journalism career, she graduated from University of Georgia with a degree in Economic and Mathematics.

Leave a Reply

Your email address will not be published. Required fields are marked *